New Zealand markets closed

Pyxis Oncology, Inc. (PYXS)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
3.6500-0.1100 (-2.93%)
At close: 04:00PM EDT
3.7000 +0.05 (+1.37%)
After hours: 07:51PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 214.94M
Enterprise value 78.69M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)9.92
Price/book (mrq)1.17
Enterprise value/revenue 4.87
Enterprise value/EBITDA 1.09

Trading information

Stock price history

Beta (5Y monthly) 1.45
52-week change 318.51%
S&P500 52-week change 323.99%
52-week high 36.8500
52-week low 31.3500
50-day moving average 34.4110
200-day moving average 33.1578

Share statistics

Avg vol (3-month) 3573.41k
Avg vol (10-day) 3326.09k
Shares outstanding 558.89M
Implied shares outstanding 658.89M
Float 839.2M
% held by insiders 119.84%
% held by institutions 146.44%
Shares short (15 May 2024) 41.96M
Short ratio (15 May 2024) 44.61
Short % of float (15 May 2024) 44.19%
Short % of shares outstanding (15 May 2024) 43.34%
Shares short (prior month 15 Apr 2024) 42.21M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 0.00%
Operating margin (ttm)-29.77%

Management effectiveness

Return on assets (ttm)-19.95%
Return on equity (ttm)-34.37%

Income statement

Revenue (ttm)16.15M
Revenue per share (ttm)0.37
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -61.46M
Net income avi to common (ttm)-57.8M
Diluted EPS (ttm)-1.3700
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)157.03M
Total cash per share (mrq)2.67
Total debt (mrq)20.78M
Total debt/equity (mrq)11.28%
Current ratio (mrq)12.19
Book value per share (mrq)3.13

Cash flow statement

Operating cash flow (ttm)-64.58M
Levered free cash flow (ttm)-29.3M